AC
Actinogen Medical Limited
ACW.AX · ASX
$0.05 -1.82% (-$0.00)
1M -8.33%
Market Cap $200.7M
P/E Ratio -
Div. Yield -
ROE 85.39%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 9.39x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 16.82%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 58.92%
Asset turnover 0.00x
ROE 85.39%
Debt
69 /100
Low Debt/Equity 0.22x
Int. coverage -60.34x
Current ratio 3.45x
Stability
56 /100
Moderate Beta 0.89x
Profitable years 0
Rev. volatility 105.05%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACW.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven G. Gourlay
Employees
6
Headquarters
Sydney
Upcoming events
24 FEB
Earnings
Upcoming earnings report